Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Email From 'Chairman' Costs Pharma Company Rs 1.9 Crore in Cyber Fraud

Farhat Nasim8 July 2025 5:54 PM IST

Bengaluru: A meticulously executed email spoofing attack has led to a massive financial loss for a pharmaceutical company. The North Division Cyber...

Madras HC Flags Licensing Gap, Says Ayurvedic Imports Must Meet Indian Drug Standards

Farhat Nasim7 July 2025 7:42 PM IST

Chennai: Observing that "it is necessary for the rule-making authority to modify existing rules, prescribe standards and prepare appropriate forms in...

Braille Labels, QR Code Voice Assistance on Drugs? CDSCO Seeks Stakeholder Comments

Govt Panel Proposes Braille Cards, Voice-Enabled QR Codes on Medicine Packs to Aid Visually Impaired

Farhat Nasim6 July 2025 11:30 AM IST

New Delhi: In a move aimed at improving accessibility for the visually impaired, the Drugs Consultative Committee (DCC) has recommended placing the...

Health Ministry Drafts Rule Change to Halve Drug Trial Approval Time from 90 to 45 Days

Govt Panel Makes This Approval Mandatory For New Drug Licenses

Farhat Nasim5 July 2025 4:44 PM IST

New Delhi: Raising serious regulatory concerns, the apex statutory body under the Central Drugs Standard Control Organisation (CDSCO), the Drugs...

Hospital Procurement Scam Uncovered in Ujjain

CBI Cracks Down on PCI Chief Montu Patel in College Bribery Scandal

Farhat Nasim4 July 2025 2:00 PM IST

Ahmedabad: The Chief of the Pharmacy Council of India (PCI), Dr Montu Kumar Patel, has come under the scanner of the Central Bureau of Investigation...

Shree Ramkrishna Exports forays into pharma space with launch of Kriam Pharma

High-Alcohol Medicinal Preparations to Come Under Schedule H1: Govt Panel Approves Rule Change

Farhat Nasim4 July 2025 12:00 PM IST

New Delhi: The Drugs Consultative Committee (DCC) has agreed to amend the Drugs Rules, 1945 to regulate the alcohol content in tinctures and other...

Trademark Clash: UNWANTED-72 Packaging Blocked, MISTAKE-72 Name Cleared by Delhi HC

Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report

Farhat Nasim3 July 2025 9:27 PM IST

New Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...

Manipal Outbids Blackstone, Fortis to Lead Race for Sahyadri Hospitals with Rs 6,838 Cr Offer

Farhat Nasim2 July 2025 4:46 PM IST

New Delhi: Manipal Health Enterprises (MHE), India's second-largest hospital chain, has emerged as the frontrunner to acquire Sahyadri Hospitals, with...

Assault upon a Medical Professional Jeopardises the Treatment of Patients Needing Urgent Care: Delhi HC

Delhi HC Rejects Modi-Mundipharma's Monopoly Claim Over 'CONTIN', Allows Limited Relief

Farhat Nasim2 July 2025 4:45 PM IST

New Delhi: Noting that a pharma company cannot claim monopoly over descriptive elements like "FE" and "CONTIN" used generically in the industry, the...

Puducherry’s Medical Students Join the Fight Against TB

DCC Recommends Licensing, Labelling Restrictions on Anti-TB Drugs to Curb Private Market Misuse

Farhat Nasim1 July 2025 11:07 PM IST

New Delhi: In a move to curb potential misuse of critical tuberculosis medications, the Drugs Consultative Committee (DCC) has recommended that...

JB Chemicals Panoli facility concludes USFDA inspection no observations

After Much Tussle, Torrent Pharma Clinches JB Chemicals Deal at Rupees 25,689 Crore Valuation

Farhat Nasim30 Jun 2025 3:07 PM IST

Mumbai: The JB Pharma divestment saga has finally seen its fate as Torrent Pharmaceuticals Limited and global investment firm KKR announced that...

Pharma Firms To Face Periodic Inspection As HC Flags Effluent Risks

Farhat Nasim29 Jun 2025 8:00 PM IST

Sikkim: The High Court of Sikkim has disposed of a Public Interest Litigation (PIL) concerning the unauthorised release of effluents and extraction of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok